Elisabetta Setola

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Performance and clinical utility of two targeted multigene panels for GIST molecular characterization.

Performance and clinical utility of two targeted multigene panels for GIST molecular characterization.

Journal: Scientific reports
Published: August 29, 2025

Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group.

Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group.

Journal: Critical reviews in oncology/hematology
Published: May 18, 2025

Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group.

Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group.

Journal: Cancer treatment reviews
Published: February 22, 2024

Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.

Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.

Journal: The oncologist
Published: December 18, 2023

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience.

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience.

Journal: BMC cancer
Published: October 12, 2022

Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis.

Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis.

Journal: Frontiers in oncology
Published: September 12, 2022

Complementary and alternative medicine in sarcoma patients treated in an Italian sarcoma center.

Complementary and alternative medicine in sarcoma patients treated in an Italian sarcoma center.

Journal: Journal of cancer research and therapeutics
Published: June 14, 2021

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group.

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group.

Journal: Cancers
Published: February 04, 2021

Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.

Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: January 19, 2021

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Journal: Cancer immunology, immunotherapy : CII
Published: October 19, 2020

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.

Journal: Cells
Published: September 22, 2020

How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?

How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?

Journal: Clinical orthopaedics and related research
Published: May 21, 2020
Showing 1-12 of 21

Last Updated: 09/26/2026